Summary Doximity’s guidance in no way reflects the positive tea leaves management discussed during the conference call. Doximity reported better than expected Q1 results with revenues of $127 million and adjusted EBITDA of $66 million, leading to a 39% increase in share price. The company minimally increased its adjusted EBITDA forecast for FY ’25, but…
During the course of the day, Monday, August 21st. we made a number of changes in our high growth model portfolio. We entered limits for all these transactions which were executed over the course of the day. As there were a number of transactions, I decided to send out one post after market close that…
As we had suggested, we started to sell some of our Doximity position to redeploy funds into more favorable situations. We were hoping for some kind of dead cat bounce but so far that hasn’t happened. We sold a little more than half of the position, i.e. 490 shares at a price of $22.39. This…
We have made some changes in our Ticker Target High Growth portfolio today, March 6th. We sold our position in Elastic. The sales price for the position was $ 66.19. That netted $45,330. Elastic’s operational performance has simply been disappointing. The technology is great, but the company has had a difficult time in converting a…
Summary Alteryx Q4 earnings were a significant upside with better than expected results for revenues, ARR and non-GAAP operating profits.The company is benefitting from a significant set of initiatives including a new go-to-market motion and a cloud analytics platform.The company is benefitting from a significant set of initiatives including a new go-to-market motion and a…
There is a saying about there being no old, bold airline pilots. The saying, in some modified form, could well apply to those commentators trying to make sense of the enterprise software space at the start of 2023. Buyers in many segments of the IT space have cut their investment in the enterprise software, almost…
Doximity: Managing headwinds in a profitable fashion 2022 was, simply put, a disastrous year for investors in high growth IT stocks-the software ETF fell by 36% and the WCLD ETF fell by 52%. Why might 2023 be any better, some might ask. There are 3 basic answers to that question. One, of course, is that valuations have been…
As suggested in previous posts, we have taken advantage of Doximity’s recent share price compression to add to our position. The shares were weak this morning, August 30, 2021 and so we doubled the size of our position by buying 225 additional shares at a price of $77.99/share. The purchase cost $!7,230. As indicated in…
After several days of risk-on bias, the market has reversed to some degree, today, Thursday, August 26, 2021. As I write this, the Nasdaq Index has declined by about 0.64%. That is about the same as the change in the S&P. The Cloud and Software indices are performing a bit better and were both down…
As mentioned in past portfolio commentaries, our holding in PTC was simply too small in terms of our portfolio management methodology. While we felt that the reaction of PTC to its most recent earnings release and guidance left the shares at a bargain valuation with an EV/S of just 8.7X, we wanted to eliminate an…